litlas
ログインアカウント作成

Diamant Thaçi

2003–2025 年に発表

別表記
Diamant Thaci
178
論文数
20,112
被引用数
71
h 指数
166
i10 指数

被引用数

Diamant Thaçi の年別被引用数1986 年: 被引用 1 件1994 年: 被引用 1 件1998 年: 被引用 1 件2001 年: 被引用 1 件2005 年: 被引用 4 件2006 年: 被引用 3 件2007 年: 被引用 7 件2008 年: 被引用 14 件2009 年: 被引用 23 件2010 年: 被引用 22 件2011 年: 被引用 30 件2012 年: 被引用 32 件2013 年: 被引用 42 件2014 年: 被引用 39 件2015 年: 被引用 94 件2016 年: 被引用 139 件2017 年: 被引用 222 件2018 年: 被引用 259 件2019 年: 被引用 771 件2020 年: 被引用 938 件2021 年: 被引用 1,036 件2022 年: 被引用 912 件2023 年: 被引用 993 件2024 年: 被引用 1,437 件2025 年: 被引用 833 件2026 年: 被引用 8 件1987〜1993 年は被引用が無いため表示していません1995〜1997 年は被引用が無いため表示していません1999〜2000 年は被引用が無いため表示していません2002〜2004 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,906 件、この内訳の 19.6%ドイツ: 引用元論文 888 件、この内訳の 9.1%イギリス: 引用元論文 656 件、この内訳の 6.7%イタリア: 引用元論文 627 件、この内訳の 6.5%カナダ: 引用元論文 572 件、この内訳の 5.9%中国: 引用元論文 504 件、この内訳の 5.2%フランス: 引用元論文 435 件、この内訳の 4.5%日本: 引用元論文 409 件、この内訳の 4.2%スペイン: 引用元論文 365 件、この内訳の 3.8%スイス: 引用元論文 304 件、この内訳の 3.1%オランダ: 引用元論文 303 件、この内訳の 3.1%デンマーク: 引用元論文 263 件、この内訳の 2.7%
0%19.6%その他 25.6%

機関

分野

  • Medicine56.2%
  • Immunology and Microbiology33.4%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Neuroscience0.5%
  • Dentistry0.3%
  • その他1.1%

トピック

  • Psoriasis: Treatment and Pathogenesis16.7%
  • Dermatology and Skin Diseases15.9%
  • Spondyloarthritis Studies and Treatments7.3%
  • Allergic Rhinitis and Sensitization5.6%
  • Asthma and respiratory diseases5.4%
  • Rheumatoid Arthritis Research and Therapies3.5%
  • その他45.6%

共著者

全論文

検索で開く
  1. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

    著者: Emma Guttman‐Yassky, Henrique D. Teixeira, Eric L. Simpson, Kim Papp, Aileen L. Pangan, Andrew Blauvelt, Diamant Thaçi, Chia‐Yu Chu, Hyuck-Ki Hong, Norito Katoh, Amy S. Paller, Brian Calimlim, Yihua Gu, Xiaofei Hu, Meng Liu, Yang Yang, John Liu, Allan R. Tenorio, Alvina D. Chu, Alan D. Irvine - The Lancet 2021 被引用: 543

  2. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

    著者: Jonathan I. Silverberg, Emma Guttman‐Yassky, Diamant Thaçi, Alan D. Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L. Simpson, Chia‐Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar Pillai, Julien Sénéschal - New England Journal of Medicine 2023 被引用: 314

  3. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial

    著者: April W. Armstrong, Melinda Gooderham, Richard B. Warren, Kim Papp, Bruce Strober, Diamant Thaçi, Akimichi Morita, Jacek C. Szepietowski, Shinichi Imafuku, Elizabeth Colston, John Throup, Sudeep Kundu, Steve Schoenfeld, Misti Linaberry, Subhashis Banerjee, Andrew Blauvelt - Journal of the American Academy of Dermatology 2022 被引用: 347

  4. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial

    著者: Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B. Gordon, Peter Foley, Phoebe Rich, C. Paul, Jerry Bagel, Elizabeth Colston, John Throup, Sudeep Kundu, Chitra Sekaran, Misti Linaberry, Subhashis Banerjee, Kim Papp - Journal of the American Academy of Dermatology 2022 被引用: 279

  5. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

    著者: Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin - New England Journal of Medicine 2014 被引用: 1,405

  6. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

    著者: Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, C. Paul, Andrew Pink, Yoko Kataoka, Chia‐Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana A. Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernán Valdez - New England Journal of Medicine 2021 被引用: 453

  7. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

    著者: Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Lisa A. Beck, Mark Boguniewicz, Lawrence Sher, Jamie Weisman, John T. O’Malley, Naimish Patel, Megan Hardin, Neil M.H. Graham, Marcella Ruddy, Xian Sun, John D. Davis, Mohamed Kamal, Faisal A. Khokhar, David M. Weinreich, George D. Yancopoulos, Bethany Beazley, Ashish Bansal, Brad Shumel - Journal of the American Academy of Dermatology 2020 被引用: 389

  8. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

    著者: Kristian Reich, Kim Papp, Andrew Blauvelt, Stephen K. Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, N. Cichanowitz, Qing Li, Kenneth Liu, Carmen La Rosa, Stuart Green, Alexa B. Kimball - The Lancet 2017 被引用: 556

  9. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

    著者: Marcus Harbord, Vito Annese, Stephan R. Vavricka, Matthieu Allez, Manuel Barreiro‐de Acosta, Kirsten Muri Boberg, Johan Burisch, Martine De Vos, Annemarie de Vries, Andrew D. Dick, Pascal Juillerat, Tom H. Karlsen, Ioannis E. Κoutroubakis, Péter L. Lakatos, Tim Orchard, Pavol Papay, Tim Raine, Max Reinshagen, Diamant Thaçi, Herbert Tilg, Franck Carbonnel - Journal of Crohn s and Colitis 2015 被引用: 808

  10. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

    著者: Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith, Kristian Reich, Michael J. Cork, Allen Radin, Q. Zhang, Bolanle Akinlade, A. Gadkari, Laurent Eckert, Thomas Hultsch, Z. Chen, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel - British Journal of Dermatology 2017 被引用: 475

  11. Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

    著者: Kim Papp, Kenneth B. Gordon, Diamant Thaçi, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab Girgis, Sudeep Kundu, Subhashis Banerjee - New England Journal of Medicine 2018 被引用: 414

  12. Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

    著者: Emma Guttman‐Yassky, Diamant Thaçi, Aileen L. Pangan, Hwanhee Hong, Kim Papp, Kristian Reich, Lisa A. Beck, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, J. Anderson, Yihua Gu, Henrique D. Teixeira, Jonathan I. Silverberg - Journal of Allergy and Clinical Immunology 2019 被引用: 357

  13. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

    著者: Joseph F. Merola, Robert Landewé, Iain B. McInnes, Philip J. Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D. Gladman, Laure Gossec, Alice B. Gottlieb, Diamant Thaçi, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates - The Lancet 2022 被引用: 158

  14. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

    著者: Mette Deleuran, Diamant Thaçi, Lisa A. Beck, Marjolein de Bruin‐Weller, Andrew Blauvelt, Seth Forman, Robert Bissonnette, Kristian Reich, Weily Soong, Iftikhar Hussaın, Peter Foley, Michihiro Hide, Jean‐David Bouaziz, Joel M. Gelfand, Lawrence Sher, Marie L. A. Schuttelaar, Chen Wang, Zhen Chen, Bolanle Akinlade, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Heribert Staudinger, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu - Journal of the American Academy of Dermatology 2019 被引用: 256

  15. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

    著者: Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, Lori Ann Cox, Anindita Banerjee, George Han, Iltefat Hamzavi, Anand K. Ganesan, Mauro Picardo, Diamant Thaçi, John E. Harris, Jung Min Bae, Katsuhiko Tsukamoto, Rodney Sinclair, Amit G. Pandya, Abigail Sloan, Dahong Yu, Kavita Gandhi, Michael S. Vincent, Brett King - Journal of the American Academy of Dermatology 2022 被引用: 146

  16. Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial

    著者: Kristian Reich, Melinda Gooderham, Diamant Thaçi, Jeffrey Crowley, Caitriona Ryan, James G. Krueger, Tsen‐Fang Tsai, Mary Flack, Yihua Gu, David Williams, Elizabeth H. Thompson, C. Paul - The Lancet 2019 被引用: 298

  17. Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

    著者: Margitta Worm, Eric L. Simpson, Diamant Thaçi, Robert Bissonnette, J.‐P. Lacour, Stefan Beissert, Makoto Kawashima, Carlos Ferrándiz, Catherine Smith, Lisa A. Beck, Kuo‐Chen Chan, Zhen Chen, Bolanle Akinlade, Thomas Hultsch, Heribert Staudinger, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - JAMA Dermatology 2019 被引用: 206

  18. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases

    著者: Hideyuki Ujiie, David Rosmarin, Michael P. Schön, Sonja Ständer, Katharina Boch, Martin Metz, Marcus Maurer, Diamant Thaçi, Enno Schmidt, Connor Cole, Kyle T. Amber, Dario Didona, Michael Hertl, Andreas Recke, Hanna Graßhoff, Alexander Hackel, Anja Schümann, Gabriela Riemekasten, Katja Bieber, Gant Sprow, Joshua Dan, Detlef Zillikens, Tanya Sezin, Angela M. Christiano, Kerstin Wolk, Robert Sabat, Khalaf Kridin, Victoria P. Werth, Ralf J. Ludwig - Frontiers in Medicine 2022 被引用: 150

  19. Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks

    著者: Esther von Stebut, Kristian Reich, Diamant Thaçi, Wolfgang Köenig, Andreas Pinter, Andreas Körber, Tienush Rassaf, Ari Waisman, Venkatesh Mani, Denise P. Yates, Jennifer Frueh, Christian Sieder, Nima Melzer, Nehal N. Mehta, Tommaso Gori - Journal of Investigative Dermatology 2018 被引用: 223

  20. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

    著者: Akimichi Morita, Bruce Strober, A. David Burden, Siew Eng Choon, Milan J. Anadkat, Slaheddine Marrakchi, Tsen‐Fang Tsai, Kenneth B. Gordon, Diamant Thaçi, Min Zheng, Na Hu, Thomas Haeufel, Christian Thoma, Mark Lebwohl - The Lancet 2023 被引用: 110

  21. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

    著者: Diamant Thaçi, Eric L. Simpson, Lisa A. Beck, Thomas Bieber, Andrew Blauvelt, Kim Papp, Weily Soong, Margitta Worm, Jacek C. Szepietowski, Howard Sofen, Makoto Kawashima, Richard Wu, Steven P. Weinstein, Neil M.H. Graham, Gianluca Pirozzi, Ariel Teper, E. Rand Sutherland, Vera Mastey, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - The Lancet 2015 被引用: 566

  22. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)

    著者: Diamant Thaçi, Eric L. Simpson, Mette Deleuran, Yoko Kataoka, Zhen Chen, Abhijit Gadkari, Laurent Eckert, Bolanle Akinlade, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu - Journal of Dermatological Science 2019 被引用: 185

  23. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

    著者: Kim Papp, Alan Menter, Mai Abe, Boni E. Elewski, Steven R. Feldman, Alice B. Gottlieb, Richard G. Langley, Thomas A. Luger, Diamant Thaçi, M. Buonanno, Pankaj Gupta, James Proulx, Shu-Ping Lan, Robert Wołk, the OPT Pivotal 1 and OPT Pivotal 2 investigators - British Journal of Dermatology 2015 被引用: 322

  24. A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

    著者: Kim Papp, Kristian Reich, C. Paul, Andrew Blauvelt, Wojciech Baran, Chantal Bolduc, D. Toth, Richard G. Langley, Jennifer Clay Cather, Alice B. Gottlieb, Diamant Thaçi, James G. Krueger, Chris B. Russell, C.E. Milmont, Jing Li, Paul Klekotka, Greg Kricorian, Ajay Nirula - British Journal of Dermatology 2016 被引用: 459